Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cystic fibrosis
Biotech
Sionna salvages AbbVie assets for assault on cystic fibrosis
Sionna has inked a deal with AbbVie to add three clinical-phase candidates to its burgeoning pipeline of cystic fibrosis prospects.
Nick Paul Taylor
Jul 16, 2024 10:00am
enGene drops cystic fibrosis program to focus on bladder cancer
Jun 14, 2024 8:20am
Vertex files FDA ask for next-gen cystic fibrosis candidate
May 7, 2024 7:30am
As pharma eyes shiny obesity drugs, Vertex tops orphan drug list
Apr 24, 2024 12:01am
Europe leads in cystic fibrosis trials, North America for AML
Apr 16, 2024 5:00pm
BiomX acquires fellow bacteria-killing virus company APT
Mar 6, 2024 9:01am
